MOLE', Daniela
 Distribuzione geografica
Continente #
NA - Nord America 2.203
EU - Europa 670
AS - Asia 474
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.355
Nazione #
US - Stati Uniti d'America 2.197
CN - Cina 245
UA - Ucraina 154
PL - Polonia 136
SG - Singapore 135
DE - Germania 110
TR - Turchia 86
IT - Italia 82
FI - Finlandia 63
GB - Regno Unito 63
SE - Svezia 43
CA - Canada 6
RU - Federazione Russa 6
BE - Belgio 5
ID - Indonesia 4
EU - Europa 3
FR - Francia 3
LT - Lituania 3
VN - Vietnam 3
BR - Brasile 2
NL - Olanda 2
CL - Cile 1
EC - Ecuador 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 3.355
Città #
Woodbridge 268
Chandler 205
Fairfield 199
Ashburn 194
Jacksonville 185
Houston 162
Warsaw 136
Ann Arbor 132
Santa Clara 127
Singapore 111
Wilmington 85
Seattle 75
Cambridge 65
Addison 52
Nanjing 44
Beijing 42
Izmir 42
Princeton 35
Boardman 32
Helsinki 30
Shanghai 26
Dearborn 25
Ferrara 25
Milan 22
Bremen 20
San Diego 17
Shenyang 17
Jinan 15
Mountain View 13
Los Angeles 12
Nanchang 12
New York 11
Washington 10
Tianjin 9
Hebei 8
Jiaxing 8
L’Aquila 8
Auburn Hills 7
Changsha 7
Frankfurt am Main 6
Orange 6
Brussels 5
Guangzhou 5
Indiana 5
Norwalk 5
Cagliari 4
Jakarta 4
London 4
Ningbo 4
Redwood City 4
Tappahannock 4
Augusta 3
Chengdu 3
Dong Ket 3
Falls Church 3
Hefei 3
Kunming 3
Lanzhou 3
Leawood 3
Munich 3
Padova 3
Taizhou 3
Bologna 2
Catanzaro 2
Hangzhou 2
Kingston 2
Ottawa 2
Rome 2
Taiyuan 2
Toronto 2
Ardabil 1
Canaro 1
Changchun 1
Des Moines 1
Dongguan 1
Falkenstein 1
Fuzhou 1
Guiyang 1
Haikou 1
Harbin 1
Kilburn 1
Knoxville 1
Navegantes 1
Newark 1
Nürnberg 1
Palmeira d'Oeste 1
Qingdao 1
San Francisco 1
San Mateo 1
Shenzhen 1
Southwark 1
Tosagua 1
Walnut 1
Weifang 1
Wuhan 1
Wuxi 1
Zhengzhou 1
Zhongshan 1
Zhoukou 1
Totale 2.627
Nome #
PKC COME NUOVO TARGET MOLECOLARE NEL CONTROLLO DELLA PROLIFERAZIONE CELLULARE DEI TUMORI NEUROENDOCRINI 179
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 165
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 140
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 136
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 135
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 127
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 126
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 125
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 123
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 122
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 120
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 119
Growth hormone excess promotes breast cancer chemoresistance 118
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 115
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 97
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 93
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 85
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 84
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 83
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 83
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 83
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 82
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 81
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 80
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 78
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 75
Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line 74
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 73
Targeting PKC in human pancreatic neuroendocrine tumor cells 70
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 69
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 60
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 58
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 58
null 40
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  29
Totale 3.385
Categoria #
all - tutte 14.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020286 0 0 0 0 0 0 53 64 47 82 28 12
2020/2021416 39 33 16 74 9 50 10 53 5 51 60 16
2021/2022313 13 28 15 3 13 18 10 8 8 34 43 120
2022/2023422 39 39 20 55 77 52 19 36 57 0 15 13
2023/2024252 21 22 11 9 16 41 9 77 3 3 2 38
2024/2025371 22 19 58 18 122 125 7 0 0 0 0 0
Totale 3.385